Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (32350)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abd El-Kader SM, El-Den Ashmawy EMS. Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol 2015; 7(6): 846-858 [PMID: 25937862 DOI: 10.4254/wjh.v7.i6.846] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i6/846.htm |
| Number | Citing Articles |
| 1 |
Shao-Jie Hu, Sha-Sha Jiang, Jin Zhang, Dan Luo, Bo Yu, Liang-Yan Yang, Hua-Hua Zhong, Mei-Wen Yang, Li-Yu Liu, Fen-Fang Hong, Shu-Long Yang. Effects of apoptosis on liver aging. World Journal of Clinical Cases 2019; 7(6): 691-704 doi: 10.12998/wjcc.v7.i6.691
|
| 2 |
Patrick H. Sweet, Teresa Khoo, Steven Nguyen. Nonalcoholic Fatty Liver Disease. Primary Care: Clinics in Office Practice 2017; 44(4): 599 doi: 10.1016/j.pop.2017.07.003
|
| 3 |
David O. Garcia, Kristin E. Morrill, Melissa Lopez‐Pentecost, Edgar A. Villavicencio, Rosa M. Vogel, Melanie L. Bell, Yann C. Klimentidis, David G. Marrero, Cynthia A. Thomson. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin Adults. Hepatology Communications 2022; 6(6): 1322 doi: 10.1002/hep4.1896
|
| 4 |
Karen Jackson, Noa Dressler, Rotem S Ben-Shushan, Ari Meerson, Tyler W LeBaron, Snait Tamir. Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model. World Journal of Gastroenterology 2018; 24(45): 5095-5108 doi: 10.3748/wjg.v24.i45.5095
|
| 5 |
Fatemeh Yaghoubi, Mina Darand, Aazam Ahmadi Vasmehjani, Zahra Darabi, Nasir Talenezhad, Farhang Mirzavandi, Mahdieh Hosseinzadeh. Adherence to low carbohydrate diets and non-alcoholic fatty liver disease: a case control study. BMC Nutrition 2022; 8(1) doi: 10.1186/s40795-022-00625-5
|
| 6 |
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy. Journal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303
|
| 7 |
Mwense Leya, Hyuneui Jeong, Daram Yang, Tien Huyen Ton Nu Bao, Prakash Raj Pandeya, Sang-Ik Oh, Yoon-Seok Roh, Jong-Won Kim, Bumseok Kim. Hepatocyte-Specific Casein Kinase 1 Epsilon Ablation Ameliorates Metabolic Dysfunction–Associated Steatohepatitis by Up-Regulating Tumor Necrosis Factor Receptor–Associated Factor 3 in Mice. The American Journal of Pathology 2024; 194(11): 2106 doi: 10.1016/j.ajpath.2024.08.003
|
| 8 |
Eiad Janini, Bashar Fteiha, Imran Ramlawi, Mahmud Mahamid. Clinical Trajectory and Predictors of Intensive Care Unit Mortality Among Nonalcoholic Fatty Liver Disease Patients: A Retrospective Case–Control Study. Journal of Clinical and Experimental Hepatology 2023; 13(2): 218 doi: 10.1016/j.jceh.2022.11.010
|
| 9 |
Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population. Scientific Reports 2016; 6(1) doi: 10.1038/srep33255
|
| 10 |
Lourdes M. Perez-Chada, Joseph F. Merola. Comorbidities associated with psoriatic arthritis: Review and update. Clinical Immunology 2020; 214: 108397 doi: 10.1016/j.clim.2020.108397
|
| 11 |
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6563
|
| 12 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. BMJ Open Gastroenterology 2019; 6(1): e000307 doi: 10.1136/bmjgast-2019-000307
|
| 13 |
Parvin Farzanegi, Amir Dana, Zeynab Ebrahimpoor, Mahdieh Asadi, Mohammad Ali Azarbayjani. Mechanisms of beneficial effects of exercise training on non‐alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European Journal of Sport Science 2019; 19(7): 994 doi: 10.1080/17461391.2019.1571114
|
| 14 |
Pan Deng, Jazmyne Barney, Michael C. Petriello, Andrew J. Morris, Banrida Wahlang, Bernhard Hennig. Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction. Chemosphere 2019; 217: 140 doi: 10.1016/j.chemosphere.2018.10.196
|
| 15 |
Dahae Lee, Tuy An Trinh, Myoung-Sook Shin, Ki Sung Kang. Recent Advancements in Microbial Diversity. 2022; : 209 doi: 10.1016/B978-0-12-822368-0.00009-8
|
| 16 |
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
|
| 17 |
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
|
| 18 |
Chun-Ho Yun, Jing-Rong Jhuang, Meng-Ting Tsou. Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06030-z
|
| 19 |
José A González-Regueiro, Mariana Cruz-Contreras, Javier Merayo-Chalico, Ana Barrera-Vargas, Astrid Ruiz-Margáin, Alejandro Campos-Murguía, May Espin-Nasser, Braulio Martínez-Benítez, Victor H Méndez-Cano, Ricardo U Macías-Rodríguez. Hepatic manifestations in systemic lupus erythematosus. Lupus 2020; 29(8): 813 doi: 10.1177/0961203320923398
|
| 20 |
Angezwa Siboto, Akinjide Moses Akinnuga, Muhammed Bilaal Ismail, Irvin Noel Booysen, Ntethelelo Hopewell Sibiya, Phikelelani Ngubane, Andile Khathi. Investigating the Protective Effects of a Rhenium (V) Compound with Uracil-Derived Ligands on Liver Damage Associated with Prediabetes in Diet-Induced Prediabetic Rats. Diabetology 2022; 3(4): 524 doi: 10.3390/diabetology3040040
|
| 21 |
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
|
| 22 |
Hwi-Jin Im, Seung-Ju Hwang, Jin-Seok Lee, Sung-Bae Lee, Ji-Yun Kang, Chang-Gue Son. Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model. Nutrients 2020; 12(8): 2433 doi: 10.3390/nu12082433
|
| 23 |
Nayyar Ashfaq, Akash John, Abid Ali, Amina Sharif Bhatti, Hateem Qaiser. Evaluation of Liver Changes in Type-2 Diabetes Mellitus Patients using Computed Tomography. DIET FACTOR (Journal of Nutritional & Food Sciences) 2022; : 14 doi: 10.54393/df.v3i1.45
|
| 24 |
A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets. Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy. Rational Pharmacotherapy in Cardiology 2022; 17(6): 880 doi: 10.20996/1819-6446-2021-12-14
|
| 25 |
C. Lloret-Linares, L. Hachon. Adaptation posologique chez le sujet obèse. Réanimation 2015; 24(4): 367 doi: 10.1007/s13546-015-1086-y
|
| 26 |
Ondulla T. Toomer, Thien Vu, Marion Pereira, Kristina Williams. Dietary supplementation with peanut skin polyphenolic extracts (PSPE) reduces hepatic lipid and glycogen stores in mice fed an atherogenic diet. Journal of Functional Foods 2019; 55: 362 doi: 10.1016/j.jff.2019.02.041
|
| 27 |
Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
|
| 28 |
Elham Karimi-Sales, Abbas Ebrahimi-Kalan, Mohammad Reza Alipour. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism. Biomedicine & Pharmacotherapy 2019; 109: 1306 doi: 10.1016/j.biopha.2018.10.196
|
| 29 |
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. Toxicology Reports 2021; 8: 376 doi: 10.1016/j.toxrep.2021.02.010
|
| 30 |
Nithyanantham Kamalraj, Madhanagopal Sathishkumar, Mani Arunvignesh, Viswanathan Baskar, Saravanan Jebarani, Anandakumar Amutha, Mohan Deepa, Coimbatore Subramanyam Shanthi Rani, Sundaramoorthy Chandru, Ranjit Unnikrishnan, Ranjit Mohan Anjana, Mardavada Harish, Viswanathan Mohan. Retrospective analysis (2009–2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2021; 15(5): 102261 doi: 10.1016/j.dsx.2021.102261
|
| 31 |
Frances L Byrne, Kyle L Hoehn. Subclassification of fatty liver by its pathogenesis: cIEFing is believing. The Journal of Pathology 2016; 239(1): 3 doi: 10.1002/path.4702
|
| 32 |
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Computers in Biology and Medicine 2021; 131: 104243 doi: 10.1016/j.compbiomed.2021.104243
|
| 33 |
Hanaa H. Gaballah, Hemat E. El‐Horany, Duaa S. Helal. Mitigative effects of the bioactive flavonol fisetin on high‐fat/high‐sucrose induced nonalcoholic fatty liver disease in rats. Journal of Cellular Biochemistry 2019; 120(8): 12762 doi: 10.1002/jcb.28544
|
| 34 |
Mahmud Mahamid, Naim Mahroum, Nicola Bragazzi, Kasem Shalaata, Yarden Yavne, Mohammad Adawi, Howard Amital, Abdulla Watad. Folate and B12 Levels Correlate with Histological Severity in NASH Patients. Nutrients 2018; 10(4): 440 doi: 10.3390/nu10040440
|
| 35 |
Oana Belei, Laura Olariu, Andreea Dobrescu, Tamara Marcovici, Otilia Marginean. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents. Journal of Pediatric Endocrinology and Metabolism 2017; 30(11) doi: 10.1515/jpem-2017-0252
|
| 36 |
Rusdiana Rusdiana, Siti Syarifah, Yunita Sari Pane, Sry Suryani Widjaja, Dwi Rita Anggraini. The Effects of High Fat Diet on the Liver of the White Rat Model Obesity. Open Access Macedonian Journal of Medical Sciences 2022; 10(A): 709 doi: 10.3889/oamjms.2022.9383
|
| 37 |
Zahra Maleki, Shima Jazayeri, Omid Eslami, Farzad Shidfar, Agha Fatemeh Hosseini, Shahram Agah, Hamed Norouzi. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Complementary Therapies in Medicine 2019; 44: 44 doi: 10.1016/j.ctim.2019.02.020
|
| 38 |
Maria Eleni Chondrogianni, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva. Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1344376
|
| 39 |
Szkup Małgorzata, Brodowski Jacek, Owczarek Aleksander Jerzy, Choręza Piotr, Jurczak Anna, Grochans Elżbieta. Searching for Factors Raising the Incidence of Metabolic Syndrome Among 45-60-Year-Old Women. Aging and disease 2018; 9(5): 831 doi: 10.14336/AD.2017.1027
|
| 40 |
Lorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, Yemi Oluboyede, Luke Vale, Laura Ternent, Maria-Magdalena Balp, Lynda Doward, Clifford A. Brass, Fiona Beyer, Arun Sanyal, Quentin M. Anstee. Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis. JHEP Reports 2020; 2(3): 100099 doi: 10.1016/j.jhepr.2020.100099
|
| 41 |
Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult Guidelines. Osteopathic Family Physician 2021; 13(2): 29 doi: 10.33181/13024
|
| 42 |
Vanessa Souza-Mello. Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. World Journal of Hepatology 2017; 9(2): 74-79 doi: 10.4254/wjh.v9.i2.74
|
| 43 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
|
| 44 |
María Correa‐Rodríguez, Mikel Izquierdo, Antonio García‐Hermoso, Robinson Ramírez‐Vélez. Discriminatory capacity of obesity indicators as predictors of high liver fat in US adolescents. European Journal of Clinical Investigation 2022; 52(1) doi: 10.1111/eci.13654
|
| 45 |
Amirhossein Naghipour, Ehsan Amini-Salehi, Mahdi Orang Gorabzarmakhi, Milad Shahdkar, Bahman Fouladi, Iraj Alipourfard, Zahra Momayez Sanat. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study. Systematic Reviews 2023; 12(1) doi: 10.1186/s13643-023-02299-x
|
| 46 |
Ge Meng, Fangfang Liu, Liyun Fang, Chunlei Li, Qing Zhang, Li Liu, Hongmei Wu, Huanmin Du, Hongbin Shi, Yang Xia, Xiaoyan Guo, Xing Liu, Xue Bao, Qian Su, Yeqing Gu, Fei Yu, Huijun Yang, Bin Yu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Qi Guo, Xin Chen, Kun Song, Guolin Wang, Guowei Huang, Kaijun Niu. The overall computer/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study. Annals of Medicine 2016; 48(7): 568 doi: 10.1080/07853890.2016.1219454
|
| 47 |
José Francisco Zambrano‐Zaragoza, Alejandro Vázquez‐Reyes, Ma. de Jesús Durán‐Avelar, Jorge Gutiérrez‐Franco, Norberto Vibanco‐Pérez, Juan Manuel Agraz‐Cibrián, Horacio Pérez‐Cambero, Miriam Fabiola Ayón‐Pérez. Deleted genes associated with obesity in Mexican patients diagnosed with nonalcoholic fatty liver disease. Annals of Human Genetics 2022; 86(5): 237 doi: 10.1111/ahg.12466
|
| 48 |
Roberto CATANZARO, Federica SELVAGGIO, Morena SCIUTO, Luca ZANOLI, Azam YAZDANI, Fang HE, Francesco MAROTTA. Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease. Minerva Gastroenterology 2022; 68(3) doi: 10.23736/S2724-5985.21.02818-X
|
| 49 |
Teresa Auguet, Laia Bertran, Jessica Binetti. Human Microbiome. Biochemistry 2021; 20 doi: 10.5772/intechopen.92972
|
| 50 |
Xiaoyan Zhang, Weili Yang, Junpei Wang, Yuhong Meng, Youfei Guan, Jichun Yang. FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes. Metabolism 2018; 81: 71 doi: 10.1016/j.metabol.2017.12.001
|
| 51 |
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Angiology 2022; 73(8): 701 doi: 10.1177/00033197221091317
|
| 52 |
Yun Ji, Yuan Gao, Hong Chen, Yue Yin, Weizhen Zhang. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Nutrients 2019; 11(9): 2062 doi: 10.3390/nu11092062
|
| 53 |
Miguel Rebollo-Hernanz, Yolanda Aguilera, Maria Martin-Cabrejas, Elvira de Mejia. Phytochemicals from Cocoa Shell Protect Mitochondrial Function and Alleviate Oxidative Stress in Hepatocytes via Regulation of ERK and PI3K-AKT Pathways. The 1st International e-Conference on Antioxidants in Health and Disease 2021; : 25 doi: 10.3390/msf2021002025
|
| 54 |
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content. Ultrasound in Medicine & Biology 2021; 47(4): 1067 doi: 10.1016/j.ultrasmedbio.2020.12.014
|
| 55 |
Nahla K. Ali Elkholy, Kareem M. Ramadan, Dina H. Ziada, Mohamed M. Hefeda. MRI with diffusion-weighted image in assessment of hepatic fibrosis and steatosis. Tanta Medical Journal 2022; 50(3): 211 doi: 10.4103/tmj.tmj_35_22
|
| 56 |
Ahmed Arafa, Rena Kashima, Chisa Matsumoto, Yoshihiro Kokubo. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study. Journal of Stroke and Cerebrovascular Diseases 2024; 33(1): 107495 doi: 10.1016/j.jstrokecerebrovasdis.2023.107495
|
| 57 |
Sajida Perveen, Muhammad Shahbaz, Karim Keshavjee, Aziz Guergachi. A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20166-x
|
| 58 |
Manuele Gori, Sara Maria Giannitelli, Andrea Zancla, Pamela Mozetic, Marcella Trombetta, Nicolò Merendino, Alberto Rainer. Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD‐on‐a‐chip study. Biotechnology and Bioengineering 2021; 118(1): 142 doi: 10.1002/bit.27557
|
| 59 |
Rachel Aber, Wesley Chan, Sevane Mugisha, Loydie A. Jerome-Majewska. Transmembrane emp24 domain proteins in development and disease.. Genetics Research 2019; 101 doi: 10.1017/S0016672319000090
|
| 60 |
Younes Mousania, Salman Karimi, Ali Farmani. Optical remote sensing, brightness preserving and contrast enhancement of medical images using histogram equalization with minimum cross-entropy-Otsu algorithm. Optical and Quantum Electronics 2023; 55(2) doi: 10.1007/s11082-022-04341-z
|
| 61 |
Chunmei Xu, Junyu Zhao, Xiaojun Zhou, Rui Zhang, Tianyue Xie, Zhiwei Zou, Lin Liao, Jianjun Dong. Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis. Oncotarget 2018; 9(15): 12389 doi: 10.18632/oncotarget.24222
|
| 62 |
Monika Gjorgjieva, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, Michelangelo Foti. miRNAs and NAFLD: from pathophysiology to therapy. Gut 2019; 68(11): 2065 doi: 10.1136/gutjnl-2018-318146
|
| 63 |
Bárbara L. Riestra-Candelaria, Loida A. González-Rodríguez, Wilma Rodriguez-Mojica, Luis E. Vázquez-Quiñones, Juan Carlos Jorge. Sonographic Features of the Liver Among Females With Type 2 Diabetes. Journal of Diagnostic Medical Sonography 2019; 35(3): 189 doi: 10.1177/8756479319834927
|
| 64 |
方行 周. The Regulation Mechanisms of Anthocyanins on Lipid Metabolism in Non-Alcoholic Fatty Liver. Hans Journal of Food and Nutrition Science 2015; 4(04): 116 doi: 10.12677/HJFNS.2015.44016
|
| 65 |
Julie J Loiselle, Guangdong Yang, Lingyun Wu. Hydrogen sulfide and hepatic lipid metabolism – a critical pairing for liver health. British Journal of Pharmacology 2020; 177(4): 757 doi: 10.1111/bph.14556
|
| 66 |
Rosmawati Mohamed, Christina Yip, Shikha Singh. Understanding the knowledge, awareness, and attitudes of the public towards liver diseases in Malaysia. European Journal of Gastroenterology & Hepatology 2023; 35(7): 742 doi: 10.1097/MEG.0000000000002548
|
| 67 |
Sylwia Ziółkowska, Piotr Czarny, Janusz Szemraj. Impaired base excision repair is related to the pathogenesis of non-alcoholic fatty liver disease. Acta Universitatis Lodziensis. Folia Biologica et Oecologica 2020; 16: 5 doi: 10.18778/1730-2366.16.01
|
| 68 |
Mei-Lang Kung, Siao Muk Cheng, Yun-Han Wang, Kai-Pi Cheng, Yu-Lin Li, Yi-Tsen Hsiao, Bertrand Chin-Ming Tan, Yun-Wen Chen. Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice. Communications Biology 2024; 7(1) doi: 10.1038/s42003-024-06215-4
|
| 69 |
Castillo Tomas Augusto, María de la Paz Scribano Parada, Micaela Milagros Rossi, Franco Signorini, Ismael Fonseca, María del Carmen Baez. Pharmacological Action of Atorvastatin and Metformin on Non-alcoholic
Fatty Liver Disease on an Experimental Model of Metabolic Syndrome. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2021; 21(3): 194 doi: 10.2174/1871523022666230223090714
|
| 70 |
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
|
| 71 |
R Guo, S Nair, Y Zhang, J Ren. RETRACTED ARTICLE: Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis. International Journal of Obesity 2017; 41(9): 1403 doi: 10.1038/ijo.2017.128
|
| 72 |
Miey Park, Anshul Sharma, Hana Baek, Jin-Young Han, Junho Yu, Hae-Jeung Lee. Stevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in db/db Mice Hepatocytes. Antioxidants 2022; 11(12): 2496 doi: 10.3390/antiox11122496
|
| 73 |
Wei Xuan, Dandan Song, Youyou Yan, Ming Yang, Yan Sun, Nicoletta Guaragnella. A Potential Role for Mitochondrial DNA in the Activation of Oxidative Stress and Inflammation in Liver Disease. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/5835910
|
| 74 |
Joong-won Jeon, Nakwon Choi, Seung Hwan Lee, Jong Hwan Sung. Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis. Biomedical Microdevices 2020; 22(4) doi: 10.1007/s10544-020-00519-y
|
| 75 |
Bihan Liu, Shanshan Wang, Ming Xu, Yanan Ma, Rui Sun, Huiguo Ding, Lei Li. The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.899859
|
| 76 |
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. International Journal of Molecular Sciences 2019; 20(20): 5037 doi: 10.3390/ijms20205037
|
| 77 |
Ilenia Martinelli, Maria Vittoria Micioni Di Bonaventura, Michele Moruzzi, Consuelo Amantini, Federica Maggi, Maria Gabriella Gabrielli, Alessandro Fruganti, Andrea Marchegiani, Fabrizio Dini, Carlotta Marini, Carlo Polidori, Giulio Lupidi, Francesco Amenta, Seyed Khosrow Tayebati, Carlo Cifani, Daniele Tomassoni. Effects of Prunus cerasus L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity. Nutrients 2020; 12(5): 1308 doi: 10.3390/nu12051308
|
| 78 |
Aya Ghnaim, Iqbal M. Lone, Nadav Ben Nun, Fuad A. Iraqi. Unraveling the Host Genetic Background Effect on Internal Organ Weight Influenced by Obesity and Diabetes Using Collaborative Cross Mice. International Journal of Molecular Sciences 2023; 24(9): 8201 doi: 10.3390/ijms24098201
|
| 79 |
Oh Young Kwon, Seung Up Kim, Sang Hoon Ahn, Yeonsoo Jang. Self-Management and Associated Factors among Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 20(1): 667 doi: 10.3390/ijerph20010667
|
| 80 |
Megan M. Knuth, Jing Xue, Marwa Elnagheeb, Raad Z. Gharaibeh, Sarah A. Schoenrock, Susan McRitchie, Cory Brouwer, Susan J. Sumner, Lisa Tarantino, William Valdar, R. Scott Rector, Jeremy M. Simon, Folami Ideraabdullah. Early life exposure to vitamin D deficiency impairs molecular mechanisms that regulate liver cholesterol biosynthesis, energy metabolism, inflammation, and detoxification. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1335855
|
| 81 |
Juraj Krznarić, Adriana Vince. The Role of Non-Alcoholic Fatty Liver Disease in Infections. Life 2022; 12(12): 2052 doi: 10.3390/life12122052
|
| 82 |
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?. Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
|
| 83 |
João A. Amorim, Giuseppe Coppotelli, Anabela P. Rolo, Carlos M. Palmeira, Jaime M. Ross, David A. Sinclair. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nature Reviews Endocrinology 2022; 18(4): 243 doi: 10.1038/s41574-021-00626-7
|
| 84 |
Claudia Sanna, Chiara Rosso, Milena Marietti, Elisabetta Bugianesi. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. International Journal of Molecular Sciences 2016; 17(5): 717 doi: 10.3390/ijms17050717
|
| 85 |
Mengqing Zhang, Chengcheng Guo, Zonglin Li, Xiaoling Cai, Xin Wen, Fang Lv, Chu Lin, Linong Ji. Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways. Pharmaceuticals 2024; 17(10): 1287 doi: 10.3390/ph17101287
|
| 86 |
Fatemeh Izadi, Amirhosein Farrokhzad, Babak Tamizifar, Mohammad Javad Tarrahi, Mohammad Hassan Entezari. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trial. Phytotherapy Research 2021; 35(1): 477 doi: 10.1002/ptr.6826
|
| 87 |
Ryotaro Bouchi, Yujiro Nakano, Norihiko Ohara, Takato Takeuchi, Masanori Murakami, Masahiro Asakawa, Yuriko Sasahara, Mitsuyuki Numasawa, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa. Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes. Cardiovascular Diabetology 2016; 15(1) doi: 10.1186/s12933-016-0384-7
|
| 88 |
Cosmas Rinaldi Adithya Lesmana, Yoppi Kencana, Ikhwan Rinaldi, Juferdy Kurniawan, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP). Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 15 doi: 10.2147/DMSO.S330526
|
| 89 |
Vinicius P. Vieira Alves, Lisa Qiu, Maisam Abu-El-Haija, Siobhan Tellez, David S. Vitale, Tom K. Lin, Jean A. Tkach, Jaimie D. Nathan, Jonathan R. Dillman, Andrew T. Trout. Prospective characterization of incident hepatic steatosis in pediatric and adolescent patients after total pancreatectomy with islet autotransplantation. Pancreatology 2022; 22(8): 1175 doi: 10.1016/j.pan.2022.09.242
|
| 90 |
Panayiotis Louca, Abraham S. Meijnikman, Ana Nogal, Francesco Asnicar, Ilias Attaye, Amrita Vijay, Afroditi Kouraki, Alessia Visconti, Kari Wong, Sarah E. Berry, Emily R. Leeming, Olatz Mompeo, Francesca Tettamanzi, Andrei-Florin Baleanu, Mario Falchi, George Hadjigeorgiou, Jonathan Wolf, Yair I.Z. Acherman, Arnold W. Van de Laar, Victor E.A. Gerdes, Gregory A. Michelotti, Paul W. Franks, Nicola Segata, Massimo Mangino, Tim D. Spector, William J. Bulsiewicz, Max Nieuwdorp, Ana M. Valdes, Cristina Menni. The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery. Cell Reports Medicine 2023; 4(4): 100993 doi: 10.1016/j.xcrm.2023.100993
|
| 91 |
Vuong Vu, Young Mee Kim, Moonjae Cho. Effects of SCFAs and TMAO on non-alcoholic fatty liver disease indicating the therapeutic benefits of plant-based diet, and supplemental prebiotics, probiotics and synbiotics. Applied Biological Chemistry 2023; 66(1) doi: 10.1186/s13765-022-00755-1
|
| 92 |
Michelle J Allen, Rachael Doran, David Brain, Elizabeth E Powell, James O’Beirne, Patricia C Valery, Adrian Barnett, Ruvini Hettiarachchi, Ingrid J Hickman, Sanjeewa Kularatna. A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09934-2
|
| 93 |
J. E. Nelson, P. Handa, B. Aouizerat, L. Wilson, L. A. Vemulakonda, M. M. Yeh, K. V. Kowdley. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Alimentary Pharmacology & Therapeutics 2016; 44(11-12): 1253 doi: 10.1111/apt.13824
|
| 94 |
Mohammad Jalali, Mehran Rahimlou, Marzieh Mahmoodi, Seyedeh Parisa Moosavian, Michael E. Symonds, Ronak Jalali, Morteza Zare, Mohammad Hadi Imanieh, Cristina Stasi. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 2020; 159: 104799 doi: 10.1016/j.phrs.2020.104799
|
| 95 |
Martina Chiurazzi, Nunzia Cacciapuoti, Mariastella Di Lauro, Gilda Nasti, Margherita Ceparano, Elisabetta Salomone, Bruna Guida, Maria Serena Lonardo. The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight/Obese Adults with NAFLD. Nutrients 2022; 14(22): 4750 doi: 10.3390/nu14224750
|
| 96 |
Amir Hajighasem, Parvin Farzanegi, Zohreh Mazaheri, Marjan Naghizadeh, Ghoncheh Salehi. Effects of resveratrol, exercises and their combination on Farnesoid X receptor, Liver X receptor and Sirtuin 1 gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liver. PeerJ 2018; 6: e5522 doi: 10.7717/peerj.5522
|
| 97 |
Mahmud Mahamid, Wiliam Nseir, Tawfik Khoury, Baker Mahamid, Adi Nubania, Kamal Sub-Laban, Joel Schifter, Amir Mari, Wisam Sbeit, Eran Goldin. Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. European Journal of Gastroenterology & Hepatology 2021; 33(12): 1578 doi: 10.1097/MEG.0000000000001902
|
| 98 |
Ryotaro Bouchi, Tatsuya Fukuda, Takato Takeuchi, Yujiro Nakano, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa. Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetes. BMC Obesity 2017; 4(1) doi: 10.1186/s40608-017-0163-3
|
| 99 |
Dong-Woo Lim, Shambhunath Bose, Jing-Hua Wang, Han Seok Choi, Young-Mi Kim, Young-Won Chin, Song-Hee Jeon, Jai-Eun Kim, Hojun Kim. Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways. Scientific Reports 2017; 7(1) doi: 10.1038/srep45425
|
| 100 |
Hao Guo, Alexey B. Tikhomirov, Alexandria Mitchell, Ian Patrick Joseph Alwayn, Haishan Zeng, Kevin C. Hewitt. Real-time assessment of liver fat content using a filter-based Raman system operating under ambient light through lock-in amplification. Biomedical Optics Express 2022; 13(10): 5231 doi: 10.1364/BOE.467849
|
| 101 |
Xiaofang Zhang, Caoxin Huang, Xuejun Li, Zhaoshui Shangguan, Wenjing Wei, Suhuan Liu, Shuyu Yang, Yijie Liu. HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01515-5
|
| 102 |
DooYong Park, Byungul Lim, On Lee. Association Between Relative Grip Strength, Insulin Resistance, and Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Adults: A Prospective Cohort Study. Metabolic Syndrome and Related Disorders 2024; doi: 10.1089/met.2024.0177
|
| 103 |
Gautam Maddineni, Sri J. Obulareddy, Ruchir D. Paladiya, Rohan R. Korsapati, Shika Jain, Herby Jeanty, Fnu Vikash, Nayanika C. Tummala, Samatha Shetty, Arezoo Ghazalgoo, Abinash Mahapatro, Viswanadh Polana, Dhruvan Patel. The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment. Annals of Medicine & Surgery 2024; 86(8): 4714 doi: 10.1097/MS9.0000000000002276
|
| 104 |
Filiz Fusun Bolukbas, Seyda İgnak, Ozlem Unay Demirel, Yavuz Furuncuoglu, Ferhan Mantar, Sercen Cansu Sertel, Filiz Yarimcan Saglam, Cengiz Bolukbas. Alkole bağlı olmayan karaciğer yağlanmasında transient elastografi (Fibroscan) tekniği ile tespit edilen fibrozis skoru ile serum Vitamin B12 arasındaki ilişkinin araştırılması. Anadolu Kliniği Tıp Bilimleri Dergisi 2017; doi: 10.21673/anadoluklin.297152
|
| 105 |
Iryna Lobach, Joshua Sampson, Siarhei Lobach, Alexander Alekseyenko, Alexandra Piryatinska, Tao He, Li Zhang. A simple approximation to the bias of gene–environment interactions in case–control studies with silent disease. Genetic Epidemiology 2019; 43(3): 292 doi: 10.1002/gepi.22186
|
| 106 |
Atilla BEKTAS, Meltem ULUSOY. Akdeniz diyeti ve Non alkolik yağlı karaciğer hastalığı. Troia Medical Journal 2023; doi: 10.55665/troiamedj.1363991
|
| 107 |
Thibault Fraisse, Léa Savey, Véronique Hentgen, Linda Rossi‐Semerano, Isabelle Koné‐Paut, Gilles Grateau, Sophie Georgin‐Lavialle, Stéphanie Ducharme‐Bénard. Non‐amyloid liver involvement in familial Mediterranean fever: A systematic literature review. Liver International 2020; 40(6): 1269 doi: 10.1111/liv.14445
|
| 108 |
Pamela A. Kushner, Michael E. Cobble. Hypertriglyceridemia: the importance of identifying patients at risk. Postgraduate Medicine 2016; 128(8): 848 doi: 10.1080/00325481.2016.1243005
|
| 109 |
Yao Zhang, Kongdong Li, Anqi Kong, Yang Zhou, Dongfeng Chen, Jie Gu, Haifeng Shi. Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants. Ecotoxicology and Environmental Safety 2021; 217: 112256 doi: 10.1016/j.ecoenv.2021.112256
|
| 110 |
Jose A. Godoy-Lugo, Max A. Thorwald, Dora A. Mendez, Ruben Rodriguez, Daisuke Nakano, Akira Nishiyama, Rudy M. Ortiz. Glucose Increases Hepatic Mitochondrial Antioxidant Enzyme Activities in Insulin Resistant Rats Following Chronic Angiotensin Receptor Blockade. International Journal of Molecular Sciences 2022; 23(18): 10897 doi: 10.3390/ijms231810897
|
| 111 |
Qian Yu, Yann-yin Lee, Zheng-yun Xia, Emily C. Liong, Jia Xiao, George L. Tipoe. S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation. European Journal of Nutrition 2021; 60(2): 961 doi: 10.1007/s00394-020-02305-1
|
| 112 |
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseases. Phytotherapy Research 2020; 34(6): 1191 doi: 10.1002/ptr.6598
|
| 113 |
Amal A. Mohamed, Ahmed El-Demery, Eman Al-Hussain, Shroouk Mousa, Ahmed Abdel Halim, Sahar M. Mostafa, Reda S. Abdelghany, Seham M. Mahmoud, Mohammad A. Elkady, Khaled Raafat, Alshymaa A. Hassnine, Mohamed M. Omran. NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients. Journal of Genetic Engineering and Biotechnology 2021; 19(1): 157 doi: 10.1186/s43141-021-00257-5
|
| 114 |
Yu-Ying Xu, Juan Ge, Mo-Han Zhang, Wen-Jie Sun, Jun Zhang, Pei-Lin Yu, Yi-Fan Zheng, Jun Yang, Xin-Qiang Zhu. Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley Rats. International Journal of Toxicology 2016; 35(6): 634 doi: 10.1177/1091581816653363
|
| 115 |
Li‐Li Qu, Bin Yu, Zheng Li, Wen‐Xiao Jiang, Jian‐Dong Jiang, Wei‐Jia Kong. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway. Phytotherapy Research 2016; 30(3): 402 doi: 10.1002/ptr.5541
|
| 116 |
Omar T. Ahmed, Alina M. Allen. Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2019; 18(4): 455 doi: 10.1007/s11901-019-00499-5
|
| 117 |
Umesh K. Goand, Inklisan Patel, Saurabh Verma, Shubhi Yadav, Debalina Maity, Naveen Singh, Sachin Vishwakarma, Shivam Rathaur, Richa Garg, Jiaur R. Gayen. Immunometabolic impact of pancreastatin inhibitor PSTi8 in MCD induced mouse model of oxidative stress and steatohepatitis. Cytokine 2023; 171: 156354 doi: 10.1016/j.cyto.2023.156354
|
| 118 |
Shuowen Wang, Wanyu Zhang, Zijun Wang, Zhuo Liu, Xiaoyu Yi, Jianxin Wu. Mettl3-m6A-YTHDF1 axis promotion of mitochondrial dysfunction in metabolic dysfunction–associated steatotic liver disease. Cellular Signalling 2024; 121: 111303 doi: 10.1016/j.cellsig.2024.111303
|
| 119 |
Ge Meng, Bo Zhang, Fei Yu, Chunlei Li, Qing Zhang, Li Liu, Hongmei Wu, Yang Xia, Xue Bao, Hongbin Shi, Qian Su, Yeqing Gu, Liyun Fang, Huijun Yang, Bin Yu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Huanli Jiao, Bangmao Wang, Qi Guo, Livia A. Carvalhoa, Zhong Sun, Kun Song, Ming Yu, Kaijun Niu. Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population. European Journal of Nutrition 2018; 57(6): 2113 doi: 10.1007/s00394-017-1485-0
|
| 120 |
Francesco Calabrese, Vittoria Disciglio, Isabella Franco, Paolo Sorino, Caterina Bonfiglio, Antonella Bianco, Angelo Campanella, Tamara Lippolis, Pasqua Pesole, Maurizio Polignano, Mirco Vacca, Giusy Caponio, Gianluigi Giannelli, Maria De Angelis, Alberto Osella. A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients. Nutrients 2022; 14(9): 1773 doi: 10.3390/nu14091773
|
| 121 |
Ann-Yae Na, Jung Jae Jo, Oh Kwang Kwon, Riya Shrestha, Pil Joung Cho, Kyu Min Kim, Sung Hwan Ki, Tae Hee Lee, Tae Won Jeon, Tae Cheon Jeong, Sangkyu Lee. Investigation of nonalcoholic fatty liver disease-induced drug metabolism by comparative global toxicoproteomics. Toxicology and Applied Pharmacology 2018; 352: 28 doi: 10.1016/j.taap.2018.05.021
|
| 122 |
Shahin Riyahi Malayeri, Hamzeh MohamMadi Firooz Abad, Omid Soleimani Ghaleh, Soheila Azarkhosh. Moderate aerobic exercise and probiotic intake on FOXA1 gene expression
in non-alcoholic fatty liver animal model: An Experimental Study. Journal of Sports Physiology and Athletic Conditioning 2022; 2(4): 14 doi: 10.61186/jspac.36413.2.4.14
|
| 123 |
Guoli Cao, Tingzhuang Yi, Qianqian Liu, Min Wang, Shaohui Tang. Alcohol consumption and risk of fatty liver disease: a meta-analysis. PeerJ 2016; 4: e2633 doi: 10.7717/peerj.2633
|
| 124 |
Kyungeh An, Angela Starkweather, Jamie Sturgill, Jeanne Salyer, Richard K. Sterling. Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease. Nursing Research 2019; 68(1): 29 doi: 10.1097/NNR.0000000000000319
|
| 125 |
Yuchang Li, Liting Chen, Lu Li, Chantal Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito, Lucy Golden-Mason, Hugo R. Rosen, Jeremy J. Wolff, Cristina I. Silvescu, Samuel Garza, Garett Cheung, Tiffany Huang, Jinjiang Fan, Martine Culty, Bangyan Stiles, Kinji Asahina, Vassilios Papadopoulos. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. iScience 2021; 24(5): 102457 doi: 10.1016/j.isci.2021.102457
|
| 126 |
Yangwenjie Wang, Jessica Lavier, Weicheng Hua, Lijing Gong, Hao Wei, Jianxiong Wang, Maxime Pellegrin, Grégoire P. Millet, Ying Zhang. Effects of Six Weeks of Hypoxia Exposure on Hepatic Fatty Acid Metabolism in ApoE Knockout Mice Fed a High-Fat Diet. Life 2022; 12(10): 1535 doi: 10.3390/life12101535
|
| 127 |
Amir Hajighasem, Parvin Farzanegi, Zohreh Mazaheri. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. Archives of Physiology and Biochemistry 2019; 125(2): 142 doi: 10.1080/13813455.2018.1441872
|
| 128 |
Wen-Pei Chang, Yu-Pei Chang. Correlation between Component Factors of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Nurses: An Observational and Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 19(23): 16294 doi: 10.3390/ijerph192316294
|
| 129 |
Poredoš P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Bajuk Studen K, Šabović M, Ježovnik MK. Endocrine Disorders and Peripheral Arterial Disease – A Series of Reviews
Cushing Syndrome-Cortisol Excess. Current Vascular Pharmacology 2024; 22(4): 236 doi: 10.2174/0115701611272145231106053914
|
| 130 |
Ningning Chen, Qiuli Shan, Yu Qi, Wei Liu, Xiaojun Tan, Jinsong Gu. Transcriptome analysis in normal human liver cells exposed to 2, 3, 3′, 4, 4′, 5 - Hexachlorobiphenyl (PCB 156). Chemosphere 2020; 239: 124747 doi: 10.1016/j.chemosphere.2019.124747
|
| 131 |
Junhan Li, Lei Huang, Wei Xiong, Yu Qian, Minghu Song. Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway. Biochemical and Biophysical Research Communications 2022; 603: 35 doi: 10.1016/j.bbrc.2022.03.008
|
| 132 |
Can Jiang, Yuriko Saiki, Shuto Hirota, Kosei Iwata, Xinyue Wang, Yutaka Ito, Keigo Murakami, Takehiro Imura, Jun Inoue, Atsushi Masamune, Akiyoshi Hirayama, Masafumi Goto, Toru Furukawa. Ablation of Dual-Specificity Phosphatase 6 Protects against Nonalcoholic Fatty Liver Disease via Cytochrome P450 4A and Mitogen-Activated Protein Kinase. The American Journal of Pathology 2023; 193(12): 1988 doi: 10.1016/j.ajpath.2023.09.003
|
| 133 |
Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg, Peter P. Pramstaller. Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02130-z
|
| 134 |
Charina M. Ramirez, Adam M. Lopez, Stephen D. Turley. Lysosomal Acid Lipase Activity: A Tool for the Detection and Management of Fatty Liver Disease?. EBioMedicine 2015; 2(7): 638 doi: 10.1016/j.ebiom.2015.06.008
|
| 135 |
Maria Luíza R. P. Lima, Laura H. R. Leite, Carolina R. Gioda, Fabíola O. P. Leme, Claudia A. Couto, Cândido C. Coimbra, Virginia H. R. Leite, Teresa Cristina A. Ferrari. A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/9127076
|
| 136 |
Vidyasagar Naik Bukke, Archana Moola, Gaetano Serviddio, Gianluigi Vendemiale, Francesco Bellanti. Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease. World Journal of Gastroenterology 2022; 28(48): 6909-6921 doi: 10.3748/wjg.v28.i48.6909
|
| 137 |
G. V. Konyukhov, E. D. Fedorov, S. A. Budzinsky, P. L. Chernyakevich. The unusual endoscopic finding in a patient presenting with the chronic duodenal bulb ulcer complicated by hemorrhage. Dokazatel'naya gastroenterologiya 2016; 5(1): 22 doi: 10.17116/dokgastro20165122-25
|
| 138 |
Tuukka Taipale, Ilkka Seppälä, Emma Raitoharju, Nina Mononen, Leo-Pekka Lyytikäinen, Thomas Illig, Melanie Waldenberger, Markus Juonala, Nina Hutri-Kähönen, Niku Oksala, Mika Kähönen, Olli Raitakari, Terho Lehtimäki. Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28563-y
|
| 139 |
Hong-Ying Li, Zong-Gen Peng. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease. Biochemical Pharmacology 2022; 197: 114933 doi: 10.1016/j.bcp.2022.114933
|
| 140 |
Moti Rosenstock, Leo Tseng, Andrew Pierce, Elliot Offman, Chao-Yin Chen, R. Will Charlton, Maya Margalit, Hank Mansbach. The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers. Journal of Pharmacology and Experimental Therapeutics 2023; 387(2): 204 doi: 10.1124/jpet.123.001618
|
| 141 |
Tanvi Singla, Komal N Muneshwar, Aniket G Pathade, Seema Yelne. Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues. Cureus 2023; doi: 10.7759/cureus.45884
|
| 142 |
Pian Xiong, Yong-Fen Zhu. Soy diet for nonalcoholic fatty liver disease. Medicine 2021; 100(22): e25817 doi: 10.1097/MD.0000000000025817
|
| 143 |
María del Carmen Baez, Mariana Tarán, Mónica Moya, María de la Paz Scribano Parada. Modulation of Oxidative Stress in Heart Disease. 2019; : 313 doi: 10.1007/978-981-13-8946-7_12
|
| 144 |
Xiaohong Zhao, Xuexue Shi, Haifeng Gu, Wenjing Zhou, Qin Zhang. Association between handgrip strength, nonalcoholic fatty liver disease, advanced hepatic fibrosis and its modifiers: Evidence from the NHANES database of the USA. Journal of Gastroenterology and Hepatology 2023; 38(10): 1734 doi: 10.1111/jgh.16150
|
| 145 |
Miguel Rebollo-Hernanz, Yolanda Aguilera, Maria A. Martin-Cabrejas, Elvira Gonzalez de Mejia. Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways. Antioxidants 2022; 11(1): 136 doi: 10.3390/antiox11010136
|
| 146 |
Jon R. Beck, Antoneal Lawrence, Amar S. Tung, Edward N. Harris, Cliff I. Stains. Interrogating Endogenous Protein Phosphatase Activity with Rationally Designed Chemosensors. ACS Chemical Biology 2016; 11(1): 284 doi: 10.1021/acschembio.5b00506
|
| 147 |
Sofia Enhörning, Léone Malan. Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities. Endocrine 2019; 65(2): 304 doi: 10.1007/s12020-019-01977-y
|
| 148 |
Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, Inara Samnani, Aniqa Abdul Rasool, Anmol Mohan, Um Ul Wara, Usha Tejwaney, Vikash Kumar. Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review. Journal of International Medical Research 2023; 51(9) doi: 10.1177/03000605231197058
|
| 149 |
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
Abstract(353) |
Core Tip(412) |
Full Article(HTML)(2280)
|
Full Article with Cover (PDF)-1817K(81)
|
Full Article (Word)-765K(15)
|
Audio-1282K(10)
|
Peer-Review Report-233K(47)
|
Answering Reviewers-203K(44)
|
Supplementary Material-59K(56)
|
Full Article (PDF)-1390K(139)
|
Full Article (XML)-191K(37)
|
Times Cited (3)
|
Total Visits (5218)
|
Open
|
| 150 |
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD. Journal of Clinical Medicine 2020; 9(3): 870 doi: 10.3390/jcm9030870
|
| 151 |
Tianjiao Li, Wei Guo, Zhanxiang Zhou. Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology. Biomolecules 2021; 12(1): 57 doi: 10.3390/biom12010057
|
| 152 |
A. Yu. Filippova. Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis.. Medicni perspektivi (Medical perspectives) 2020; 25(1): 65 doi: 10.26641/2307-0404.2020.1.200403
|
| 153 |
Madison M. Stokes, Heather M. Holahan. Comorbidities present in hidradenitis suppurativa. Dermatological Reviews 2022; 3(2): 58 doi: 10.1002/der2.126
|
| 154 |
|
| 155 |
Hui Cheng, Na Xu, Wenxia Zhao, Jingjing Su, Mengru Liang, Zhongwen Xie, Xianli Wu, Qinglin Li. (‐)‐Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high‐fat diet. Molecular Nutrition & Food Research 2017; 61(11) doi: 10.1002/mnfr.201700303
|
| 156 |
Jaclyn E. Welles, Holly Lacko, Yuka Imamura Kawasawa, Michael D. Dennis, Leonard S. Jefferson, Scot R. Kimball. An integrative approach to assessing effects of a short-term Western diet on gene expression in rat liver. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032293
|
| 157 |
Yeli Wang, Manja Koch, Romina di Giuseppe, Kirsten Evans, Jan Borggrefe, Ute Nöthlings, Aase Handberg, Majken K Jensen, Wolfgang Lieb. Associations of Plasma CD36 and Body Fat Distribution. The Journal of Clinical Endocrinology & Metabolism 2019; 104(9): 4016 doi: 10.1210/jc.2019-00368
|
| 158 |
Chanbin Lee, Jieun Kim, Youngmi Jung. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells 2019; 8(10): 1259 doi: 10.3390/cells8101259
|
| 159 |
Maggie A. Stanislawski, Jessica Shaw, Elizabeth Litkowski, Ethan M. Lange, Wei Perng, Dana Dabelea, Leslie A. Lange. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. The Journal of Pediatrics 2020; 220: 146 doi: 10.1016/j.jpeds.2020.01.031
|
| 160 |
Zichuan Zhang, Peize Wang, Fei Guo, Xinmin Liu, Taiyang Luo, Yang Guan, Hui Chen, Zhanhong Wang, L Zhao, Xiaohai Ma, Qiang Lv, Yin Zhang, Junping Kang, Tong Liu, Xiaohui Liu, Jian-Zeng Dong, Rong Bai. Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance. Journal of International Medical Research 2018; 46(9): 3959 doi: 10.1177/0300060518782780
|
| 161 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. Toxicology and Applied Pharmacology 2020; 401: 115101 doi: 10.1016/j.taap.2020.115101
|
| 162 |
Ya-Ling Yang, Pei-Wen Wang, Feng-Sheng Wang, Hung-Yu Lin, Ying-Hsien Huang. miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(18): 6884 doi: 10.3390/ijms21186884
|
| 163 |
Layth Mahdi, Allon Kahn, Radhika Dhamija, Hugo E. Vargas. Hepatic Steatosis Resulting From LMNA-Associated Familial Lipodystrophy. ACG Case Reports Journal 2020; 7(4): e00375 doi: 10.14309/crj.0000000000000375
|
| 164 |
Elhadi M. Yahia, José de Jesús Ornelas‐Paz, Tatiana Emanuelli, Eduardo Jacob‐Lopes, Leila Queiroz Zepka, Braulio Cervantes‐Paz. Fruit and Vegetable Phytochemicals. 2017; : 285 doi: 10.1002/9781119158042.ch15
|
| 165 |
Seoung-Woo Lee, Su-Min Baek, Young-Jin Lee, Tae-Un Kim, Jae-Hyuk Yim, Jun-Hyeok Son, Hee-Yeon Kim, Kyung-Ku Kang, Jong Hun Kim, Man Hee Rhee, Sang-Joon Park, Seong-Kyoon Choi, Jin-Kyu Park. Ginsenoside Rg3-enriched Korean Red Ginseng extract attenuates Non-Alcoholic Fatty Liver Disease by way of suppressed VCAM-1 expression in liver sinusoidal endothelium. Journal of Ginseng Research 2023; 47(3): 429 doi: 10.1016/j.jgr.2022.10.005
|
| 166 |
Wentao Wu, Aozi Feng, Wen Ma, Daning Li, Shuai Zheng, Fengshuo Xu, Didi Han, Jun Lyu. Worldwide long-term trends in the incidence of nonalcoholic fatty liver disease during 1990–2019: A joinpoint and age-period-cohort analysis. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.891963
|
| 167 |
Di Cao, Mengyi Li, Yang Liu, He Jin, Dawei Yang, Hui Xu, Han Lv, JIa Liu, Peng Zhang, Zhongtao Zhang, Zhenghan Yang. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study. BMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00821-6
|
| 168 |
Felix Westcott, David J. Dearlove, Leanne Hodson. Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk. Atherosclerosis 2024; 394: 117237 doi: 10.1016/j.atherosclerosis.2023.117237
|
| 169 |
Raissa Silva Bacelar de Andrade, Luiz Felipe de Carvalho França, Larissa dos Santos Pessoa, Bruno de Almeida Arrais Landim, Ayane Araújo Rodrigues, Even Herlany Pereira Alves, David Di Lenardo, Hélio Mateus Silva Nascimento, Francisca Beatriz de Melo Sousa, André Luiz dos Reis Barbosa, Jand‐Venes Rolim Medeiros, Any Carolina Cardoso Guimarães Vasconcelos, Daniel Fernando Pereira Vasconcelos. High‐fat diet aggravates the liver disease caused by periodontitis in rats. Journal of Periodontology 2019; 90(9): 1023 doi: 10.1002/JPER.18-0564
|
| 170 |
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver disease. Nutrition & Food Science 2019; 49(1): 75 doi: 10.1108/NFS-04-2018-0119
|
| 171 |
Huan Li, Chang Wang, Qing Wang, Xuehua Liu, Juanjuan Zhang, He Zhang, Wenjie Fei, Hang Zhao, Luping Ren. Oxymatrine Alleviates High-Fat-High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through an Untargeted Metabonomics Study. Diabetes, Metabolic Syndrome and Obesity 2023; : 4013 doi: 10.2147/DMSO.S428864
|
| 172 |
Wen-Chung Huang, Po-Chen Liao, Chun-Hsun Huang, Sindy Hu, Shih-Chun Huang, Shu-Ju Wu. Osthole attenuates lipid accumulation, regulates the expression of inflammatory mediators, and increases antioxidants in FL83B cells. Biomedicine & Pharmacotherapy 2017; 91: 78 doi: 10.1016/j.biopha.2017.04.051
|
| 173 |
Michael H. Le, Pardha Devaki, Nghiem B. Ha, Dae Won Jun, Helen S. Te, Ramsey C. Cheung, Mindie H. Nguyen, Ming-Lung Yu. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLOS ONE 2017; 12(3): e0173499 doi: 10.1371/journal.pone.0173499
|
| 174 |
Faezah Hussain, Sreetama Basu, Javen Jun Hao Heng, Lit-Hsin Loo, Daniele Zink. Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling. Archives of Toxicology 2020; 94(8): 2749 doi: 10.1007/s00204-020-02778-3
|
| 175 |
Aleksandra Filippova. NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH OBESITY: INTERCONNECTION BETWEEN BODY MASS, CHANGES OF LIPID METABOLISM AND CONCOMITANT PATHOLOGY OF BILIARY TRACT. EUREKA: Health Sciences 2016; 4: 3 doi: 10.21303/2504-5679.2016.00115
|
| 176 |
Regina Inês Kunz, Angélica Novi Capelassi, Ana Cláudia Paiva Alegre-Maller, Maria Lúcia Bonfleur, Lucinéia de Fátima Chasko Ribeiro, Rose Meire Costa, Maria Raquel Marçal Natali. Sericin as treatment of obesity: morphophysiological effects in obese mice fed with high-fat diet. Einstein (São Paulo) 2019; 18 doi: 10.31744/einstein_journal/2020AO4876
|
| 177 |
Hye Won Lee, Myunghwa Kim, Jin Youn, Shikha Singh, Sang Hoon Ahn. Liver Diseases in South Korea: A Pulse Check of the Public’s Knowledge, Awareness, and Behaviors. Yonsei Medical Journal 2022; 63(12): 1088 doi: 10.3349/ymj.2022.0332
|
| 178 |
Alvile Kasarinaite, Matthew Sinton, Philippa T. K. Saunders, David C. Hay. The Influence of Sex Hormones in Liver Function and Disease. Cells 2023; 12(12): 1604 doi: 10.3390/cells12121604
|
| 179 |
Efstathia Thymiakou, Alaa Othman, Thorsten Hornemann, Dimitris Kardassis. Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A. Metabolism 2020; 110: 154307 doi: 10.1016/j.metabol.2020.154307
|
| 180 |
C. Durán‐Vian, M.T. Arias‐Loste, J.L. Hernández, V. Fernández, M. González, P. Iruzubieta, L. Rasines, C. González‐Vela, J.P. Vaqué, R. Blanco, J. Crespo, M.A. González‐López. High prevalence of non‐alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors. Journal of the European Academy of Dermatology and Venereology 2019; 33(11): 2131 doi: 10.1111/jdv.15764
|
| 181 |
Catalina M. Mascaró, Cristina Bouzas, Sofía Montemayor, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Pere-Antoni Borràs, J. Alfredo Martínez, Josep A. Tur. Impact of Physical Activity Differences Due to COVID-19 Pandemic Lockdown on Non-Alcoholic Fatty Liver Parameters in Adults with Metabolic Syndrome. Nutrients 2022; 14(12): 2370 doi: 10.3390/nu14122370
|
| 182 |
Viviane Brandão Amorim, Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Amanda Almeida Miranda, Cláudia Cravo Moreira, Flávia Ferreira Fernandes, Carlos Frederico Ferreira Campos, Nathalie Carvalho Leite, Renata de Mello Perez, Rosana Souza Rodrigues. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World Journal of Hepatology 2020; 12(9): 661-671 doi: 10.4254/wjh.v12.i9.661
|
| 183 |
Catalina M. Mascaró, Cristina Bouzas, Sofia Montemayor, Miguel Casares, Isabel Llompart, Lucía Ugarriza, Pere-Antoni Borràs, J. Alfredo Martínez, Josep A. Tur. Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome. Nutrients 2022; 14(9): 1813 doi: 10.3390/nu14091813
|
| 184 |
Iryna Lobach, Joshua Sampson, Siarhei Lobach, Li Zhang. Gene–environment interactions in case–control studies with silent disease. Genetic Epidemiology 2018; 42(6): 551 doi: 10.1002/gepi.22135
|
| 185 |
Doaa El Amrousy, Esam Elgendy, Mohiee El-Deen Awad, Osama El Razaky. Three-dimensional speckle tracking echocardiography for early detection of left ventricular dysfunction in children with non-alcoholic fatty liver diseases. Cardiology in the Young 2021; 31(4): 562 doi: 10.1017/S104795112000445X
|
| 186 |
Andreas Geier, Mary E. Rinella, Maria-Magdalena Balp, Sarah Jane McKenna, Clifford A. Brass, Raymond Przybysz, Jennifer Cai, Amanda Knight, Meghan Gavaghan, Tanya Howe, Daniel Rosen, Vlad Ratziu. Real-World Burden of Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2021; 19(5): 1020 doi: 10.1016/j.cgh.2020.06.064
|
| 187 |
Lingxuan An, Ulrich Wirth, Dominik Koch, Malte Schirren, Moritz Drefs, Dionysios Koliogiannis, Hanno Niess, Joachim Andrassy, Markus Guba, Alexandr V. Bazhin, Jens Werner, Florian Kühn. Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD. Metabolites 2023; 13(1): 101 doi: 10.3390/metabo13010101
|
| 188 |
Arinc Ozturk, Ramin Mohammadi, Theodore T. Pierce, Sagar Kamarthi, Manish Dhyani, Joseph R. Grajo, Kathleen E. Corey, Raymond T. Chung, Atul K. Bhan, Jagpreet Chhatwal, Anthony E. Samir. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2020; 46(4): 972 doi: 10.1016/j.ultrasmedbio.2019.12.020
|
| 189 |
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua, Onofrio Cuomo, Katia Grillone, Caterina Riillo, Giulio Caridà, Francesca Scionti, Caterina Labanca, Caterina Romeo, Maria Anna Siciliano, Maria D'Apolito, Cristina Napoli, Martina Montesano, Valentina Farenza, Valentina Uppolo, Michele Tafuni, Federica Falcone, Giuseppe D'Aquino, Natale Daniele Calandruccio, Francesco Luciano, Licia Pensabene, Pierosandro Tagliaferri, Pierfrancesco Tassone. miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review. Molecular Therapy - Nucleic Acids 2022; 27: 1191 doi: 10.1016/j.omtn.2022.02.005
|
| 190 |
Liat Mlynarsky, Dalit Schlesinger, Roni Lotan, Muriel Webb, Zamir Halpern, Erwin Santo, Oren Shibolet, Shira Zelber-Sagi. Non-alcoholic fatty liver disease is not associated with a lower health perception. World Journal of Gastroenterology 2016; 22(17): 4362-4372 doi: 10.3748/wjg.v22.i17.4362
|
| 191 |
Wen‐Jing Liu, Wei‐Wen Chen, Jia‐Ying Chen, Yi‐Bin Sun, Dennis Chang, Chen‐Xiang Wang, Jin‐Dong Xie, Wei Lin, Shao‐Hua Li, Wen Xu, Yan‐Xiang Lin, Yan‐Fang Zheng, Xian Zhou, Ming‐Qing Huang. Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice. Phytotherapy Research 2023; doi: 10.1002/ptr.8010
|
| 192 |
Inhye Kim, Mi-lang Kyun, Hyewon Jung, Ji-In Kwon, Jeongha Kim, Ju-Kang Kim, Yu Bin Lee, Young-In Kwon, Kyoung-Sik Moon. In Vitro Nonalcoholic Fatty Liver Disease Model Elucidating the Effect of Immune Environment on Disease Progression and Alleviation. ACS Omega 2024; 9(23): 25094 doi: 10.1021/acsomega.4c02433
|
| 193 |
Bonglee Kim, Moon‐Jea Woo, Chul‐Soo Park, Sang‐Hun Lee, Jin‐Soo Kim, Boim Kim, Seho An, Sung‐Hoon Kim. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid‐Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT‐1 Pathway and in Acute Hyperlipidemia Mouse Model. Phytotherapy Research 2017; 31(1): 132 doi: 10.1002/ptr.5741
|
| 194 |
Manuela Abbate, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Silvia Tejada, Itziar Abete, M. Ángeles Zulet, Antoni Sureda, J. Alfredo Martínez, Josep A. Tur. Albuminuria Is Associated with Hepatic Iron Load in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome. Journal of Clinical Medicine 2021; 10(14): 3187 doi: 10.3390/jcm10143187
|
| 195 |
E. V. Rogoznaya, N. G. Ignatov, K. A. Matosyan, A. N. Oranskaya, K. G. Gurevich. Obesity: the new view of the old problem. Dokazatel'naya gastroenterologiya 2016; 5(1): 16 doi: 10.17116/dokgastro20165116-20
|
| 196 |
Zahra Eslami, Abdorreza E. Moghanlou, Yahya M.N. P. Kandi, Mehdi S. Arabi, Alireza Norouzi, Hamidreza Joshaghani. Atorvastatin and Flaxseed Effects on Biochemical Indices and Hepatic fat of NAFLD Model in Rats. Advanced Biomedical Research 2023; 12(1) doi: 10.4103/abr.abr_21_22
|
| 197 |
Mooli Raja Gopal Reddy, Gundluri Venkata Asha, Sravan Kumar Manchiryala, Uday Kumar Putcha, Ayyalasomayajula Vajreswari, Shanmugam M. Jeyakumar. High-Fat Diet Elevates Liver Docosahexaenoic Acid Possibly through Over-Expression of Very Long-Chain Fatty Acid Elongase 2 in C57BL/6J Mice. International Journal for Vitamin and Nutrition Research 2019; 89(1-2): 62 doi: 10.1024/0300-9831/a000432
|
| 198 |
Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(20): 11128 doi: 10.3390/ijms222011128
|
| 199 |
Emad H. M. Hassanein, Hanan S. Althagafy, Mohammad A. Baraka, Haitham Amin. Hepatoprotective effects of diosmin: a narrative review. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03297-z
|
| 200 |
Xiangjin Meng, Xin Guo, Jing Zhang, Junji Moriya, Junji Kobayashi, Reimon Yamaguchi, Sohsuke Yamada. Acupuncture on ST36, CV4 and KI1 Suppresses the Progression of Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Metabolites 2019; 9(12): 299 doi: 10.3390/metabo9120299
|
| 201 |
Zaida Zainal, Huzwah Khaza'ai, Ammu Kutty Radhakrishnan, Sui Kiat Chang. Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studies. Food Research International 2022; 156: 111175 doi: 10.1016/j.foodres.2022.111175
|
| 202 |
Peter I. Chater, Matthew D. Wilcox, Jeffrey P. Pearson, Iain A. Brownlee. The impact of dietary fibres on the physiological processes governing small intestinal digestive processes. Bioactive Carbohydrates and Dietary Fibre 2015; 6(2): 117 doi: 10.1016/j.bcdf.2015.09.002
|
| 203 |
Huifang Kang, Zhiwang Zhang, Lin Yu, Yixing Li, Mingzhen Liang, Lei Zhou. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation. Journal of Cellular Biochemistry 2018; 119(7): 5676 doi: 10.1002/jcb.26746
|
| 204 |
Efstathia Thymiakou, Maria Tzardi, Dimitris Kardassis. Impaired hepatic glucose metabolism and liver-α-cell axis in mice with liver-specific ablation of the Hepatocyte Nuclear Factor 4α (Hnf4a) gene. Metabolism 2023; 139: 155371 doi: 10.1016/j.metabol.2022.155371
|
| 205 |
Anil Chauhan, Laith R. Sultan, Emma E. Furth, Lisa P. Jones, Vandana Khungar, Chandra M. Sehgal. Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis. Journal of Clinical Ultrasound 2016; 44(9): 580 doi: 10.1002/jcu.22382
|
| 206 |
C. von Loeffelholz, P. Horn, A.L. Birkenfeld, R.A. Claus, B.U. Metzing, S. Döcke, G. Jahreis, R. Heller, S. Hoppe, M. Stockmann, J.F. Lock, A. Rieger, M.O. Weickert, U. Settmacher, F. Rauchfuß, A.F.H. Pfeiffer, M. Bauer, C. Sponholz. Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease. Journal of Investigative Surgery 2016; 29(5): 266 doi: 10.3109/08941939.2016.1149640
|
| 207 |
Sejeong Kim, Jae Yeon Joung, Dae-Kyung Kang, Nam Su Oh, Yohan Yoon. Anti-obesity effects of Lactobacillus rhamnosus 4B15, and its synergy with hydrolysed lactose skim milk powder. International Dairy Journal 2021; 123: 104997 doi: 10.1016/j.idairyj.2021.104997
|
| 208 |
Tarana Arman, Katherine D. Lynch, Michelle L. Montonye, Michael Goedken, John D. Clarke. Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats. Toxins 2019; 11(7): 398 doi: 10.3390/toxins11070398
|
| 209 |
Hepatoprotective effects of red beetroot‐based beverages against CCl4‐induced hepatic stress inSprague Dawleyrats. Journal of Food Biochemistry 2019; 43(12) doi: 10.1111/jfbc.13057
|
| 210 |
Ganggang Wang, Xiaowei Shen, Yicun Wang, Huanhua Lu, Hua He, Xiaoliang Wang. Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1168499
|
| 211 |
Ashish C. Sinha, Rajeshwari Subramaniam, Hemkumar Pushparaj, Ajisha Aravindan. Oxford Textbook of Anaesthesia for the Obese Patient. 2021; : 167 doi: 10.1093/med/9780198757146.003.0017
|
| 212 |
A. Link, C. Thon, S. Sydor, A. Canbay. Mikrobiota und nichtalkoholische Fettlebererkrankung. Der Gastroenterologe 2019; 14(3): 179 doi: 10.1007/s11377-019-0348-z
|
| 213 |
Akshata Gandhe, Sonia Kumari, Masilamani Elizabeth Sobhia. Rational design of FXR agonists: a computational approach for NASH therapy. Molecular Diversity 2023; doi: 10.1007/s11030-023-10766-9
|
| 214 |
Chee‐Kiat Tan, George Boon‐Bee Goh, Jin Youn, Jacques Chak‐Kwan Yu, Shikha Singh. Public awareness and knowledge of liver health and diseases in Singapore. Journal of Gastroenterology and Hepatology 2021; 36(8): 2292 doi: 10.1111/jgh.15496
|
| 215 |
Surasak Saokaew, Shada Kanchanasuwan, Piyaporn Apisarnthanarak, Aphinya Charoensak, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa, Nathorn Chaiyakunapruk. Clinical risk scoring for predicting non‐alcoholic fatty liver disease in metabolic syndrome patients (NAFLD‐MS score). Liver International 2017; 37(10): 1535 doi: 10.1111/liv.13413
|
| 216 |
Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. SAGE Open Medicine 2020; 8 doi: 10.1177/2050312120933804
|
| 217 |
Hyeon-Ji Kim, Hye-Jin Jeon, Dong-Gun Kim, Joo-Yun Kim, Jae-Jung Shim, Jae-Hwan Lee. Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(18): 9870 doi: 10.3390/ijms25189870
|
| 218 |
Any Carolina Cardoso Guimarães Vasconcelos, Daniel Fernando Pereira Vasconcelos, Felipe Rodolfo Pereira da Silva, Luiz Felipe de Carvalho França, Even Herlany Pereira Alves, David Di Lenardo, Larissa dos Santos Pessoa, Pedro Duarte Novaes, André Luiz dos Reis Barbosa, Arya Mani, Flávia Sammartino Mariano, Jand‐Venes Rolim Medeiros, Aldeídia Pereira de Oliveira. Periodontitis causes abnormalities in the liver of rats. Journal of Periodontology 2019; 90(3): 295 doi: 10.1002/JPER.18-0226
|
| 219 |
Galal A. AL-SAMHARI, Gaber M. AL-MUSHIKI, Rashi TAMRAKAR, Gibirima ABDULLAHI, YUE-Dong LIN, XIAN-Yan TANG. Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease. Journal of Nutritional Science and Vitaminology 2021; 67(6): 366 doi: 10.3177/jnsv.67.366
|
| 220 |
Hye-Rin Noh, Guoyan Sui, Jin Woo Lee, Feng Wang, Jeong-Su Park, Yuanqiang Ma, Hwan Ma, Ji-Won Jeong, Dong-Su Shin, Xuefeng Wu, Bang-Yeon Hwang, Yoon Seok Roh. Jolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway. Biomolecules & Therapeutics 2024; 32(6): 793 doi: 10.4062/biomolther.2024.033
|
| 221 |
Sou Hyun Kim, Chawon Yun, Doyoung Kwon, Yun-Hee Lee, Jae-Hwan Kwak, Young-Suk Jung. Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells. Molecules 2023; 28(3): 1476 doi: 10.3390/molecules28031476
|
| 222 |
Jibeom Lee, Hyeonhui Kim, Yun-Won Kang, Yumin Kim, Moon-young Park, Ji-Hong Song, Yunju Jo, Tam Dao, Dongryeol Ryu, Junguee Lee, Chang-Myung Oh, Sangkyu Park. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease. Experimental & Molecular Medicine 2023; 55(7): 1479 doi: 10.1038/s12276-023-01033-w
|
| 223 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 224 |
Felix F. Lillich, John D. Imig, Ewgenij Proschak. Multi-Target Approaches in Metabolic Syndrome. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.554961
|
| 225 |
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damage. World Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
|
| 226 |
Matthew C. Sinton, David C. Hay, Amanda J. Drake. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0702-5
|
| 227 |
Yohei Owada, Takafumi Tamura, Tomohito Tanoi, Yusuke Ozawa, Yoshio Shimizu, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Toshiya Matsukawa, Hiroko Isoda, Nobuhiro Ohkohchi. Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features. Pathology International 2018; 68(1): 12 doi: 10.1111/pin.12612
|
| 228 |
Mahnoor Akram, Akash John, Amina Sharif Bhatti, Miss Esha, Abid Ali. Frequency of Acute and Chronic Liver Diseases Diagnosed on Computed Tomography. Pakistan BioMedical Journal 2022; doi: 10.54393/pbmj.v5i4.375
|
| 229 |
Maryam Tabasi, Manoochehr Makvandi, Ali Teimoori, Maryam Dastoorpoor, Hamid Moradzadegan, Mahdi Parsanahad, Roya Pirmoradi, Chiman Karami. Epidemiology and Molecular Detection of HAV, HBV, and HCV in Patients with Acute Hepatitis Symptoms in Ahvaz. Jundishapur Journal of Microbiology 2018; 11(5) doi: 10.5812/jjm.63317
|
| 230 |
Rachelle Haber, Fatima Zarzour, Malak Ghezzawi, Natalie Saadeh, Dania S. Bacha, Lama Al Jebbawi, Marlene Chakhtoura, Christos S. Mantzoros. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism 2024; 26(5): 1850 doi: 10.1111/dom.15501
|
| 231 |
Amirhossein Sahebkar, Elena Sancho, David Abelló, Jordi Camps, Jorge Joven. Novel circulating biomarkers for non‐alcoholic fatty liver disease: A systematic review. Journal of Cellular Physiology 2018; 233(2): 849 doi: 10.1002/jcp.25779
|
| 232 |
Lin Sun, Zhensheng Yue, Lin Wang. Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease. Life Medicine 2024; 3(4) doi: 10.1093/lifemedi/lnae030
|
| 233 |
Silvia Ferolla, Cláudia Couto, Luciana Costa-Silva, Geyza Armiliato, Cristiano Pereira, Flaviano Martins, Maria Ferrari, Eduardo Vilela, Henrique Torres, Aloísio Cunha, Teresa Ferrari. Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients 2016; 8(7): 397 doi: 10.3390/nu8070397
|
| 234 |
Jose Melendez-Rosado, Ali Alsaad, Fernando F. Stancampiano, William C. Palmer. Abnormal Liver Enzymes. Gastroenterology Nursing 2018; 41(6): 497 doi: 10.1097/SGA.0000000000000346
|
| 235 |
Tatheer Fatima, Zeashan Hussain, Devendra Kumar Katiyar, Rishabha Malviya. Herbal Components for the Treatment of Liver Disorders: Advances and Prospective. Current Nutrition & Food Science 2024; 20(9): 1100 doi: 10.2174/0115734013282941240103065848
|
| 236 |
Su-Kyung Shin, Hyun-Woo Cho, Seung-Eun Song, Dae-Kyu Song. Catalase and nonalcoholic fatty liver disease. Pflügers Archiv - European Journal of Physiology 2018; 470(12): 1721 doi: 10.1007/s00424-018-2195-z
|
| 237 |
Salah Alshehade, Mohammed Abdullah Alshawsh, Vikneswaran Murugaiyah, Muhammad Asif, Omayma Alshehade, Hassan Almoustafa, Raghdaa Hamdan Al Zarzour. The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions. Life Sciences 2022; 305: 120732 doi: 10.1016/j.lfs.2022.120732
|
| 238 |
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson. NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?. Current HIV/AIDS Reports 2018; 15(3): 212 doi: 10.1007/s11904-018-0392-1
|
| 239 |
Younes Mousania, Salman Karimi. Fundamental Research in Electrical Engineering. Lecture Notes in Electrical Engineering 2019; 480: 43 doi: 10.1007/978-981-10-8672-4_4
|
| 240 |
Maria Conte, Morena Martucci, Marco Sandri, Claudio Franceschi, Stefano Salvioli. The Dual Role of the Pervasive “Fattish” Tissue Remodeling With Age. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00114
|
| 241 |
N. V. Efimenko, T. M. Simonova, E. N. Chalaya, V. V. Kolomeitsev. Effectiveness of ultrasound therapy in the complex spa treatment of non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2023; (4): 70 doi: 10.31146/1682-8658-ecg-212-4-70-76
|
| 242 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena N Shirokova, Elena I Vovk, Kirill M Starostin. Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia. BMJ Open Gastroenterology 2020; 7(1): e000368 doi: 10.1136/bmjgast-2019-000368
|
| 243 |
Yara A. Zaky, Mai W. Rashad, Marwa A. Zaater, Ahmed M. El Kerdawy. Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatment. BMC Chemistry 2024; 18(1) doi: 10.1186/s13065-023-01081-3
|
| 244 |
Si-Si Jin, Xian-Fan Lin, Ju-Zeng Zheng, Qiong Wang, Hua-Qin Guan. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3. European Cytokine Network 2019; 30(3): 98 doi: 10.1684/ecn.2019.0432
|
| 245 |
Meiying Yan, Jingxuan Wang, Qijia Xuan, Tieying Dong, Juan He, Qingyuan Zhang. The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer. Clinical Breast Cancer 2017; 17(3): 195 doi: 10.1016/j.clbc.2016.12.004
|
| 246 |
George V. Dedoussis, Athina I. Amanatidou. NAFLD and NASH. 2020; : 181 doi: 10.1007/978-3-030-37173-9_10
|
| 247 |
Hiroe Go, Jin Ah Ryuk, Joo Tae Hwang, Byoung Seob Ko. Effects of three different formulae of Gamisoyosan on lipid accumulation induced by oleic acid in HepG2 cells. Integrative Medicine Research 2017; 6(4): 395 doi: 10.1016/j.imr.2017.08.004
|
| 248 |
Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Burhanuddin Sohail Rangwala. Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241274310
|
| 249 |
Maria João Meneses, Regina Silvestre, Inês Sousa-Lima, Maria Paula Macedo. Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders. International Journal of Molecular Sciences 2019; 20(16): 4049 doi: 10.3390/ijms20164049
|
| 250 |
Garrett R. Casey, Cliff I. Stains. Interrogating Protein Phosphatases with Chemical Activity Probes. Chemistry – A European Journal 2018; 24(31): 7810 doi: 10.1002/chem.201705194
|
| 251 |
Yang Liu, Kevin D. Croft, Jose Caparros-Martin, Fergal O'Gara, Trevor A. Mori, Natalie C. Ward. Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease. Archives of Biochemistry and Biophysics 2021; 711: 109032 doi: 10.1016/j.abb.2021.109032
|
| 252 |
D. Santhosh Reddy, P. Rajalakshmi. A Novel Web Application Framework for Ubiquitous Classification of Fatty Liver Using Ultrasound Images. 2019 IEEE 5th World Forum on Internet of Things (WF-IoT) 2019; : 502 doi: 10.1109/WF-IoT.2019.8767283
|
| 253 |
Jin Hyun Park, In Sil Choi, Kyung-Do Han, Hyunkyung Park, Ki Hwan Kim, Jin-Soo Kim. Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study. Clinical Breast Cancer 2020; 20(4): e450 doi: 10.1016/j.clbc.2020.02.004
|
| 254 |
Yaw A Wiafe, Ijeoma C Anyitey-Kokor, Richmond A Nmai, Mary Afihene, Lewis R Roberts. Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference Standard. Cureus 2023; doi: 10.7759/cureus.40756
|
| 255 |
Punyisa Boonchai, Chayanis Kositamongkol, Suchanart Jitrukthai, Sukumal Phothirat, Euarat Mepramoon, Pongpol Nimitpunya, Weerachai Srivanichakorn, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Rungsima Tinmanee, Naruemit Sayabovorn, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa. Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome. Journal of Clinical Medicine 2022; 11(9): 2445 doi: 10.3390/jcm11092445
|
| 256 |
Duygu Yazici, Ismail Ogulur, Yagiz Pat, Huseyn Babayev, Elena Barletta, Sena Ardicli, Manal Bel imam, Mengting Huang, Jana Koch, Manru Li, Debbie Maurer, Urszula Radzikowska, Pattraporn Satitsuksanoa, Stephan R. Schneider, Na Sun, Stephan Traidl, Alexandra Wallimann, Sebastian Wawrocki, Damir Zhakparov, Danielle Fehr, Reihane Ziadlou, Yasutaka Mitamura, Marie-Charlotte Brüggen, Willem van de Veen, Milena Sokolowska, Katja Baerenfaller, Kari Nadeau, Mubeccel Akdis, Cezmi A. Akdis. The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions. Seminars in Immunology 2023; 70: 101846 doi: 10.1016/j.smim.2023.101846
|
| 257 |
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model. Microorganisms 2023; 11(10): 2466 doi: 10.3390/microorganisms11102466
|
| 258 |
Ahmad Hazim, Dyah Purnamasari, Kemal F. Kalista, C. Rinaldi A. Lesmana, Pringgodigdo Nugroho. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2): 1431 doi: 10.1016/j.dsx.2019.01.058
|
| 259 |
Hui Chen, Sylvère Durand, Olivia Bawa, Mélanie Bourgin, Léa Montégut, Flavia Lambertucci, Omar Motiño, Sijing Li, Uxía Nogueira-Recalde, Gerasimos Anagnostopoulos, Maria Chiara Maiuri, Guido Kroemer, Isabelle Martins. Liver Carcinogenesis. Methods in Molecular Biology 2024; 2769: 199 doi: 10.1007/978-1-0716-3694-7_15
|
| 260 |
Wenyang Hou, Swati Gupta, Marie-Claude Beauchamp, Libin Yuan, Loydie A. Jerome-Majewska, Arun Rishi. Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2. PLOS ONE 2017; 12(8): e0182995 doi: 10.1371/journal.pone.0182995
|
| 261 |
Gino A. Kurian, Bhavana Sivakumar. Phospholipases in Physiology and Pathology. 2023; : 3 doi: 10.1016/B978-0-443-15177-4.00007-8
|
| 262 |
A-Rang Im, Won-Kyung Yang, Yang-Chun Park, Seung Hyung Kim, Sungwook Chae. Hepatoprotective Effects of Insect Extracts in an Animal Model of Nonalcoholic Fatty Liver Disease. Nutrients 2018; 10(6): 735 doi: 10.3390/nu10060735
|
| 263 |
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 2022; 29(7): 4478 doi: 10.3390/curroncol29070356
|
| 264 |
Lais S Garcêz, Camila R Avelar, Nedja S S Fonseca, Priscila R F Costa, André C Lyra, Carla M Cunha, Rosangela P Jesus, Lucivalda P M Oliveira. Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2021; 79(12): 1321 doi: 10.1093/nutrit/nuaa146
|
| 265 |
Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1035159
|
| 266 |
Yao Teng, Zixuan Zhao, Farah Tasnim, Xiaozhong Huang, Hanry Yu. A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids. Biomaterials 2021; 275: 120904 doi: 10.1016/j.biomaterials.2021.120904
|
| 267 |
Harpal S. Dhaliwal, Ripudaman Singh, Abin M. Abraham, Rajan Sharma, N. K. Goyal, Rajat Soloman, Pankaj Bansal, Amandeep Goyal. Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2021; 66(12): 4197 doi: 10.1007/s10620-020-06794-2
|